When do the Eylea and Eylea HD patents expire?

Drugs.com

Official answer

by Drugs.com

Eylea and Eylea HD patents are due to run out from 2023 to 2039; however, these should not be taken as definite dates as there are many ways drug companies can extend their patents, for example, by changing the formulation of their product. For example, the original patent term for Regeneron was extended from May 23, 2020, to June 16, 2023.

The current patent expiry dates for Eylea are as follows:

  • Composition of matter (for a composition of at least 2 ingredients): June 16, 2023
  • Formulation patents (4 of these): June 14, 2027 (for 2); June 21, 2027; March 22, 2026
  • Methods of treatment patents (3 of these): March 22, 2026, and January 11, 2032 (for 2)
  • Method of manufacturing: March 22, 2026
  • Composition of matter (supplementary protection certificate): May 23, 2025.

    • At least 5 Eylea HD patents are the same as Eylea patents, typically extending the patent expiry date.

  • One new patent, US11103552B2 which relates to high concentration VEGF receptor fusion protein containing formulations, has a patent expiry date of 15 May 2039.

    • Because pharmaceutical companies make about 80% of their overall revenue while their drug is on patent, they will often try many legal techniques to extend their patents for as long as they can. Once patents fully expire, generic companies can copy the formulation, saving the cost of years of research, and undercutting the original company’s prices significantly.

    Related medical questions

    Disclaimer

    Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

    The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

    Popular Keywords

    AI Assitant